EDAP TMS SA (EDAP)
-NasdaqGM | Prev Close: | 4.06 |
|---|
| Open: | N/A |
|---|
| Bid: | 3.72 x 500 |
|---|
| Ask: | 4.59 x 500 |
|---|
| 1y Target Est: | 6.00 |
|---|
| Beta: | 1.76 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.43 - 4.94 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 259,581 |
|---|
| Market Cap: | 76.28M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.63 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: EDAP TMS SA entered into definitive agreements with certain institutional investors for registered direct placement of $12 mln of ordinary shares in form of ADSs at price of $4.00/share, with warrants attachedBriefing.com(Tue, May 21)
- EDAP to Raise $12 Million in Registered Direct OfferingGlobeNewswire(Tue, May 21)
- EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year StudyGlobeNewswire(Mon, May 20)
- Edap TMS CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 16)
- EDAP Reports 23% Increase in First Quarter 2013 RevenuesGlobeNewswire(Thu, May 16)
- Q1 2013 Edap TMS Earnings Release - Before Market OpenCCBN(Thu, May 16)
- EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual MeetingGlobeNewswire(Tue, May 14)
- EDAP Schedules Webcast and Conference Call for First Quarter 2013 ResultsGlobeNewswire(Mon, May 13)
- EDAP Outlines Significant Participation at 2013 American Urological Association Annual MeetingGlobeNewswire(Wed, May 1)
- 5 Health Care Stocks Under $10 to Watchat TheStreet(Tue, Apr 30)
- EDAP Announces 23% First Quarter 2013 Revenue GrowthGlobeNewswire(Thu, Apr 11)
- EDAP TMS SA FinancialsEDGAR Online Financials(Sat, Apr 6)
- Q4 2012 Edap TMS Earnings Release - Before Market OpenCCBN(Tue, Apr 2)
- EDAP Reports Fourth Quarter 2012 and Full Year ResultsGlobeNewswire(Tue, Apr 2)
- EDAP receives FDA filing acceptance of pre-market approval applicationat theflyonthewall.com(Thu, Mar 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.17 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.45 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -2.73 |
|---|
Business Summary
EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases.
View More 
0.34%